ZA87407B - Benzazecine derivatives - Google Patents

Benzazecine derivatives

Info

Publication number
ZA87407B
ZA87407B ZA87407A ZA87407A ZA87407B ZA 87407 B ZA87407 B ZA 87407B ZA 87407 A ZA87407 A ZA 87407A ZA 87407 A ZA87407 A ZA 87407A ZA 87407 B ZA87407 B ZA 87407B
Authority
ZA
South Africa
Prior art keywords
chloro
cpds
acetyl
benzazecine
methoxybenzoyl
Prior art date
Application number
ZA87407A
Other languages
English (en)
Inventor
Werner Aschwanden
Rene Imhof
Roland Jakob
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA87407B publication Critical patent/ZA87407B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D227/00Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA87407A 1986-01-23 1987-01-20 Benzazecine derivatives ZA87407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH26686 1986-01-23

Publications (1)

Publication Number Publication Date
ZA87407B true ZA87407B (en) 1987-09-30

Family

ID=4183090

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87407A ZA87407B (en) 1986-01-23 1987-01-20 Benzazecine derivatives

Country Status (30)

Country Link
US (4) US4732979A (pt)
EP (1) EP0230967B1 (pt)
JP (1) JPS62169770A (pt)
KR (1) KR910000659B1 (pt)
CN (1) CN1013111B (pt)
AT (1) ATE68790T1 (pt)
AU (1) AU590042B2 (pt)
CS (1) CS258147B2 (pt)
DD (1) DD264431A5 (pt)
DE (1) DE3773950D1 (pt)
DK (1) DK35887A (pt)
FI (1) FI82931C (pt)
GB (1) GB2185744B (pt)
HU (1) HU197883B (pt)
IE (1) IE870167L (pt)
IL (1) IL81317A (pt)
IS (1) IS3190A7 (pt)
MC (1) MC1795A1 (pt)
MT (1) MTP996B (pt)
MW (1) MW187A1 (pt)
NO (1) NO167385C (pt)
NZ (1) NZ218987A (pt)
OA (1) OA08469A (pt)
PH (1) PH22879A (pt)
PL (1) PL263796A1 (pt)
PT (1) PT84181B (pt)
TN (1) TNSN87006A1 (pt)
YU (1) YU7087A (pt)
ZA (1) ZA87407B (pt)
ZW (1) ZW1087A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22879A (en) * 1986-01-23 1989-01-19 Hoffmann La Roche Benzazecine derivatives
IN167395B (pt) * 1987-07-21 1990-10-20 Hoffmann La Roche
EP0591582B1 (en) * 1991-08-21 1999-01-20 Eli Lilly And Company Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
EP0591583B1 (en) * 1991-08-21 2001-12-19 Eli Lilly And Company Benzo (f) quinolinones as 5-alpha-reductase inhibitors
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
WO1994022444A1 (en) * 1993-03-29 1994-10-13 Smithkline Beecham Corporation Tricyclic compounds for inhibiting platelet aggregation
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
WO1996009299A1 (en) 1994-09-20 1996-03-28 The Regents Of The University Of California Drugs to improved synaptic transmission
US20050067341A1 (en) * 2003-09-25 2005-03-31 Green Dennis H. Continuous production membrane water treatment plant and method for operating same
US7094331B2 (en) * 2003-11-05 2006-08-22 Marathon Ashland Petroleum Llc Viscosity modification of heavy hydrocarbons using dihydric alcohols
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
CN106117028B (zh) * 2016-06-14 2019-01-01 浙江永太药业有限公司 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE442586A (pt) * 1940-07-31
JPS5129710B2 (pt) * 1972-09-09 1976-08-27
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4521423A (en) * 1983-10-31 1985-06-04 Ayerst, Mckenna & Harrison, Ltd. 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
PH22879A (en) * 1986-01-23 1989-01-19 Hoffmann La Roche Benzazecine derivatives

Also Published As

Publication number Publication date
CS258147B2 (en) 1988-07-15
MC1795A1 (fr) 1987-10-22
JPS62169770A (ja) 1987-07-25
FI870220A0 (fi) 1987-01-20
PT84181A (pt) 1987-02-01
DK35887A (da) 1987-07-24
NZ218987A (en) 1990-04-26
NO167385C (no) 1991-10-30
DD264431A5 (de) 1989-02-01
EP0230967A2 (de) 1987-08-05
OA08469A (fr) 1988-07-29
GB2185744A (en) 1987-07-29
IL81317A0 (en) 1987-08-31
FI870220A (fi) 1987-07-24
PH22879A (en) 1989-01-19
ATE68790T1 (de) 1991-11-15
TNSN87006A1 (fr) 1990-01-01
AU590042B2 (en) 1989-10-26
AU6791187A (en) 1987-07-30
YU7087A (en) 1988-06-30
NO870280D0 (no) 1987-01-22
MW187A1 (en) 1987-10-14
FI82931B (fi) 1991-01-31
CS41887A2 (en) 1987-11-12
HU197883B (en) 1989-06-28
IS3190A7 (is) 1987-07-24
US4957911A (en) 1990-09-18
CN1013111B (zh) 1991-07-10
IE870167L (en) 1987-07-23
ZW1087A1 (en) 1987-08-12
IL81317A (en) 1991-06-30
KR870007132A (ko) 1987-08-17
MTP996B (en) 1987-08-21
GB2185744B (en) 1989-12-06
NO870280L (no) 1987-07-24
EP0230967A3 (en) 1988-08-31
EP0230967B1 (de) 1991-10-23
FI82931C (fi) 1991-05-10
GB8701416D0 (en) 1987-02-25
NO167385B (no) 1991-07-22
US4749791A (en) 1988-06-07
US4876340A (en) 1989-10-24
DE3773950D1 (de) 1991-11-28
PL263796A1 (en) 1988-10-27
KR910000659B1 (ko) 1991-01-31
US4732979A (en) 1988-03-22
DK35887D0 (da) 1987-01-22
PT84181B (pt) 1989-09-14
HUT44519A (en) 1988-03-28
CN87100312A (zh) 1987-09-09

Similar Documents

Publication Publication Date Title
GB2185744B (en) Benzazecine derivatives
GB2126226B (en) Pyridine derivatives
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
NZ218682A (en) Monosulphactam derivatives
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
GR3005176T3 (pt)
FI884345A0 (fi) Sackaridderivat.
NO911798D0 (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
RO96381A2 (ro) Procedeu pentru sinteza azobisciclopentancarbonitrilului
FI96606C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-etinyylisytidiini-, uridiini- ja guanosiinijohdannaisten valmistamiseksi